Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 17.10% and Operating profit at 20.91% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.56% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 17.10% and Operating profit at 20.91% over the last 5 years
3
Flat results in Mar 25
4
With ROE of 12.77%, it has a expensive valuation with a 1.22 Price to Book Value
Stock DNA
Chemicals & Petrochemicals
CNY 3,083 Million (Small Cap)
10.00
NA
1.04%
0.59
11.82%
1.18
Revenue and Profits:
Net Sales:
828 Million
(Quarterly Results - Sep 2025)
Net Profit:
60 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.95%
0%
1.95%
6 Months
-1.19%
0%
-1.19%
1 Year
27.76%
0%
27.76%
2 Years
45.75%
0%
45.75%
3 Years
1.84%
0%
1.84%
4 Years
4.96%
0%
4.96%
5 Years
-4.05%
0%
-4.05%
Hubei Kailong Chemical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.10%
EBIT Growth (5y)
20.91%
EBIT to Interest (avg)
2.50
Debt to EBITDA (avg)
3.75
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.73
Tax Ratio
14.02%
Dividend Payout Ratio
31.29%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.44%
ROE (avg)
9.56%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.22
EV to EBIT
10.84
EV to EBITDA
6.06
EV to Capital Employed
1.13
EV to Sales
1.31
PEG Ratio
0.15
Dividend Yield
1.02%
ROCE (Latest)
10.44%
ROE (Latest)
12.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
827.90
930.80
-11.06%
Operating Profit (PBDIT) excl Other Income
91.00
205.30
-55.67%
Interest
19.80
25.60
-22.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
60.30
81.10
-25.65%
Operating Profit Margin (Excl OI)
110.00%
121.90%
-1.19%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -11.06% vs -7.16% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -25.65% vs -0.25% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,670.50
3,765.00
-2.51%
Operating Profit (PBDIT) excl Other Income
785.10
785.30
-0.03%
Interest
119.50
149.90
-20.28%
Exceptional Items
-35.50
-14.60
-143.15%
Consolidate Net Profit
256.50
246.90
3.89%
Operating Profit Margin (Excl OI)
116.90%
117.60%
-0.07%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.51% vs 10.85% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 3.89% vs 58.57% in Dec 2023
About Hubei Kailong Chemical Group Co., Ltd. 
Hubei Kailong Chemical Group Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






